Expedeon AG

Expedeon (Frankfurt, PRIME: EXN) is a life sciences company with an expertise in the area of antibody conjugation and immuno-assays, with its Lightning-Link® and CaptSure™ technologies. It is also investing in its TruePrime™ technology with exciting potential in the areas of DNA manufacturing and amplification.

Alongside these core technologies, Expedeon offers a range of consumables for use primarily in research and development laboratories around the world. The Company’s current revenue generation is focused on antibody-based workflows with significant growth opportunities both in this market and the area of DNA manufacture for gene therapy applications, in particular.


Expedeon at a glance:

 

Field of Activity Expedeon offers a wide range of products covering workflows across genomics, proteomics and immunology research. The company’s innovative technologies are also licensed for commercial use in POC & clinical diagnostic such as ELISA, lateral flow and NGS based liquid biopsy applications.
Ownership Structure and Financing Investors 8%, Management 8%, Freefloat 84%. In June 2019, ODDO SEYDLER BANK was mandated as second designated sponsor to ensure continuous trading on XETRA®, improving the tradability of Expedeon shares for investors.
Partners Extensive OEM, supply and licensing agreements with partners in the life science industry worldwide, including Perkin Elmer, Merck, US Biological and Abingdon Health.
Technology Key technologies include Lightning-Link® for antibody labelling, CaptSure™ for antibody capture as well as market leading genomics technology TruePrime™ for replication and manufacture of DNA.
Products/Services Innovative, enabling, easy-to-use, robust and reliable technologies, products and custom services for life science research and diagnostic product development including NGS based liquid biopsy, whole genome amplification, antibody- and protein-labelling, and immunoassay development.
Unique Selling Point We are constantly pushing the boundaries to provide high quality, easy-to-use, cost effective solutions which enable our customers to progress their research, drug discovery or diagnostic product development programs.
Date of Incorporation/
Number of Employees
2013/105


 Contact:

 

Address Waldhofer Str. 102
69123 Heidelberg
Telefax +49 6221 3540-125/127
E-Mail info@expedeon.com
Web Address www.expedeon.com
www.investors.expedeon.com
Social Media Twitter

 

 

 

Hier kostenfrei für den Newsletter anmelden!